The US National Action Plan for Combating Multidrug-Resistant Tuberculosis (NAP) included the commitment to develop generic ancillary care packages (e.g., services and supplies that enable patients to continue therapy) for MDR-TB patients. USAID developed an approach that was pilot tested in four countries (China, Pakistan, South Africa and, Ukraine) in collaboration with NTPs and implementing partners in the field. The care package developed provided a flexible framework for countries to adapt to provide tailored supportive care to people with DR-TB through treatment completion and cure.
In 2017, the TB CARE II project held a workshop to orient stakeholders from the ten priority countries to the package and support scale-up and introduction. Workshop objectives helped participating countries:
- Critically examine the results and lessons learned from the pilot of the package in four countries to inform scale-up and introduction.
- Understand the comprehensive supportive care approach and be familiar with the tools available to support implementation at country levels.
- Based on the pilot countries’ experiences, provide practical guidance on how to implement the care package in their settings, learn best practices and tools, and approaches that worked in the pilot settings.
- Discuss successes and challenges in how to approach M&E for care package implementation and understand M&E approaches.
- Draft an introduction/expansion plan with timelines, responsibilities, and technical assistance needs identified.